Sage Therapeutics announces board member retirement

SAGE Stock  USD 5.00  0.03  0.60%   
About 52% of Sage Therapeutic's shareholders are presently thinking to get in. The analysis of the overall investor sentiment regarding Sage Therapeutic suggests that some traders are interested. The current market sentiment, together with Sage Therapeutic's historical and current headlines, can help investors time the market. In addition, many technical investors use Sage Therapeutic stock news signals to limit their universe of possible portfolio assets.
  
Sage Therapeutics announces board member retirement

Read at investing.com
Investing News at Macroaxis
  

Sage Therapeutic Current Investor Sentiment

Panic Vs Confidence

52

 
Panic
 
Confidence
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Sage Therapeutic's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Sage Therapeutic.

Sage Therapeutic Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Sage Therapeutic can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Sage Therapeutic Fundamental Analysis

We analyze Sage Therapeutic's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sage Therapeutic using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sage Therapeutic based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Total Debt

Total Debt Comparative Analysis

Sage Therapeutic is currently under evaluation in total debt category among its peers. Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.

Sage Therapeutic Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Sage Therapeutic stock to make a market-neutral strategy. Peer analysis of Sage Therapeutic could also be used in its relative valuation, which is a method of valuing Sage Therapeutic by comparing valuation metrics with similar companies.

Peers

Sage Therapeutic Related Equities

TERNTerns Pharmaceuticals   5.03   
0%
68.0%
STOKStoke Therapeutics   1.71   
0%
23.0%
NUVLNuvalent   1.43   
0%
19.0%
RLAYRelay Therapeutics   1.43   
0%
19.0%
IMCRImmunocore Holdings   0.57   
0%
7.0%
AMLXAmylyx Pharmaceuticals   0.51   
0%
6.0%
ALNYAlnylam Pharmaceuticals   0.40   
0%
5.0%
MDGLMadrigal Pharmaceuticals   0.22   
0%
2.0%
DAWNDay One   0.56   
7.0%
0%
VTYXVentyx Biosciences   0.87   
11.0%
0%
AKROAkero Therapeutics   1.08   
14.0%
0%
APLSApellis Pharmaceuticals   1.48   
20.0%
0%
INCYIncyte   2.67   
36.0%
0%
BPMCBlueprint Medicines   3.11   
42.0%
0%
ARVNArvinas   4.19   
57.0%
0%
PLRXPliant Therapeutics   5.00   
68.0%
0%
BDTXBlack Diamond   6.40   
87.0%
0%
DMACDiaMedica Therapeutics   7.31   
99.0%
0%
KRYSKrystal Biotech   7.34   
100.0%
0%

Complementary Tools for Sage Stock analysis

When running Sage Therapeutic's price analysis, check to measure Sage Therapeutic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sage Therapeutic is operating at the current time. Most of Sage Therapeutic's value examination focuses on studying past and present price action to predict the probability of Sage Therapeutic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sage Therapeutic's price. Additionally, you may evaluate how the addition of Sage Therapeutic to your portfolios can decrease your overall portfolio volatility.
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Money Managers
Screen money managers from public funds and ETFs managed around the world
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals